Skip to main content

Month: March 2020

Muudatused investorkalendris ja koroonaviiruse (COVID-19) mõju Baltika Grupile

Baltika Grupp teavitab börsi hetkeolukorrast seoses koroonaviiruse (COVID-19) puhanguga ettevõtte põhiturgudel Eestis, Lätis ja Leedus. Seoses koroonaviirusest tekkinud erakorralise olukorraga ja sellest tulenevate negatiivsete mõjude hindamisega Baltika Grupi finantspositsioonile, lükkub AS Baltika auditeeritud 2019 majandusaasta aruande kinnitamine (planeeritud avalikustamise kuupäev 26.03.2020) edasi. Baltika Grupp teavitab börsi esimesel võimalusel uuest majandusaasta aruande avalikustamise kuupäevast.Eesti, Läti ja Leedu valitsused on kehtestanud riikides eriolukorra ning sellest tulenevalt on rakendatud meetmeid, mis avaldavad ühtlasi mõju ettevõtte igapäevasele toimimisele. Leedu valitsuse otsuse alusel suleti 16. märtsil kõik Baltika Grupi brändide poed Leedus. Kaalumisel on poodide sulgemine Eestis ja Lätis.Tarne osas Baltika...

Continue reading

Preliminary results for the year ended 31 December 2019

LEI: 213800WTQKOQI8ELD692  19 March 2020OneSavings Bank plcPreliminary results for the year ended 31 December 2019Due to the Combination with Charter Court Financial Services Group plc (CCFS) this press release includes results on both a statutory and a pro forma underlying basis. The statutory basis reflects 12 months of OSB’s results and CCFS’ results from 4 October 2019 while the pro forma underlying basis assumes that the Combination occurred on 1 January 2018 and includes 12 months of results from CCFS and excludes exceptional items, integration costs and other acquisition-related items.Financial highlightsStatutory profit before tax increased 14% to £209.1m (2018: restated £182.8m1). Pro forma underlying profit before tax increased 9% to £381.1m (2018: £350.8m) The net loan book grew 105% to £18.4bn (2018: £9.0bn) on a statutory...

Continue reading

2019 Preliminary Results

Kenmare Resources plc (“Kenmare” or “the Group”)19 March 20202019 Preliminary ResultsKenmare Resources plc (LSE:KMR, ISE:KMR), one of the leading global producers of titanium minerals and zircon, which operates the Moma Titanium Minerals Mine (the “Mine” or “Moma”) in northern Mozambique, today announces its preliminary results for the twelve months to 31 December 2019.Statement from Michael Carvill, Managing Director:“While 2019 was another year of robust financial and operational performance for Kenmare, the recent outbreak of COVID-19 presents global challenges and uncertainties. The safety and wellbeing of our employees and our host communities remain our overriding priorities. To date there has not been a confirmed case of COVID-19 in Mozambique and there have been no material adverse effects on production...

Continue reading

Cramo’s CFO Aku Rumpunen and SVP Mika Kouhi to leave the company

Cramo Plc        Stock Exchange Release    19 March 2020 at 9.00 am (EET)Cramo’s CFO Aku Rumpunen and SVP Mika Kouhi to leave the companyMr Aku Rumpunen, CFO of Cramo Group and Mr Mika Kouhi, SVP M&A and Corporate Development Cramo Group have both announced that they will be stepping down from their respective roles.Mr Aku Rumpunen has been the CFO of Cramo Group since 2016 and has been a part of the Group Management Team since his previous position as SVP, Group Business Control in 2013. He leaves the company at his own request but will stay until the beginning of August to secure the financial integration with Boels Rental and facilitate the delisting of Cramo shares from Nasdaq Helsinki.‘’I would like to thank Aku for his many contributions to developing and strengthening Cramo into a pure equipment rental company. He has...

Continue reading

Cramon talous- ja rahoitusjohtaja Aku Rumpunen sekä M&A- ja Corporate Development ‑toiminnoista vastaava johtaja Mika Kouhi jättävät yhtiön

Cramo Oyj       Pörssitiedote   19.3.2020 klo 9.00Cramon talous- ja rahoitusjohtaja Aku Rumpunen sekä M&A- ja Corporate Development ‑toiminnoista vastaava johtaja Mika Kouhi jättävät yhtiönCramo-konsernin talous- ja rahoitusjohtaja Aku Rumpunen sekä M&A- ja Corporate Development ‑toiminnoista vastaava johtaja Mika Kouhi ovat molemmat ilmoittaneet irtisanoutumisestaan.Aku Rumpunen on ollut Cramo-konsernin talous- ja rahoitusjohtaja vuodesta 2016. Hän on ollut konsernin johtoryhmän jäsen vuodesta 2013, jolloin hän toimi Group Business Control ‑toiminnon johtajana. Hän jättää yrityksen omasta aloitteestaan, mutta jatkaa roolissaan elokuun alkuun saakka. Näin varmistetaan taloudellinen integraatio Boels Rentalin kanssa ja sujuvoitetaan Cramon osakkeiden poistamista Nasdaq Helsingin pörssistä.”Haluan kiittää Akua hänen panoksestaan,...

Continue reading

Gofore Plc: The Finnish National Agency for Education selected Gofore and Cybercom Finland to maintain its Studyinfo services

GOFORE PLC COMPANY ANNOUNCEMENT 19 MARCH 2020 AT 9.15  The Studyinfo.fi consists of various services that were taken into use in stages during 2013-2019. Other services of the Finnish National Agency for Education targeted for the learners can later be added to maintenance. The services are mainly used to fulfill the statutory tasks of the Finnish National Agency for Education.The maintenance of the services is carried out as expert work. Gofore and Cybercom are responsible for the integration of the underlying information systems, technical functionality and small-scale development work as part of the normal maintenance.Gofore has served the Finnish National Agency for Education since 2011. Gofore, together with Cybercom, has been building and developing the Studyinfo services since the beginning.The Finnish National Agency for Education...

Continue reading

WPD PHARMACEUTICALS’ WP1122 DRUG TO BE TESTED ON A RANGE OF VIRUSES INCLUDING CORONAVIRUS

VANCOUVER, British Columbia, March 19, 2020 (GLOBE NEWSWIRE) — WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”) a clinical stage pharmaceutical company, announces, that its license partner Moleculin Biotech, Inc. (Nasdaq: MBRX)(“Moleculin”), has entered into an agreement with a leading government funded research facility in the United States to conduct research on its patented portfolio of molecular inhibitors, including drug candidate, WP1122, for antiviral properties against a range of viruses, including Coronavirus.Published research has revealed that viral replication can be highly dependent on specific monosaccharides and has demonstrated the effectiveness of a compound known as ‘2-DG,’ a dual decoy of glucose and mannose, in the treatment of certain viruses.1 This is rooted in an emerging...

Continue reading

BW Offshore: Operational and financial update 

Operational and financial update BW Offshore is proactively taking steps to minimise risk of business interruptions due to the spread of Covid-19 coronavirus and is adhering to local public health advisory across all locations. Commercial uptime on all operating FPSOs continue to be close to 100% to date in 2020.Prioritising people, operations and partners The health and safety of employees and their families and ensuring continued safe offshore operations in cooperation with clients are the top priorities for BW Offshore. Restrictions have been introduced on international travel combined with extensive use of home office and video-meetings to reduce people gatherings and minimise risk of spreading the virus.BW Offshore has established a task force that has initiated offshore business continuity plans for each FPSO focused on;Optimising...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.